JVD 2020 #2 Successful Use of MTA Fillapex as a Sealant for Feline Root Canal Therapy of 50 Canines in 37 Cats; Thorne Flashcards Preview

JVD 2019-2021 > JVD 2020 #2 Successful Use of MTA Fillapex as a Sealant for Feline Root Canal Therapy of 50 Canines in 37 Cats; Thorne > Flashcards

Flashcards in JVD 2020 #2 Successful Use of MTA Fillapex as a Sealant for Feline Root Canal Therapy of 50 Canines in 37 Cats; Thorne Deck (9)
Loading flashcards...
1
Q

How was MTA FillapexTM used in the study?

A

As a root canal sealant with gutta percha single cone obturation

2
Q

What was considered “Successful” therapy?

A

if a preoperative PAL had healed or not formed after tx and any pre-op external inflamm root resorption (EIRR) had stabilized without progression

3
Q

What was considered “No evidence of failure (NEF)”?

A

If a PAL had remained the same or decreased in size but not completely resolved and any pre-op EIRR had stabilized without progression

4
Q

What was considered a “Failed” root canal therapy?

A

If PAL had occurred or increased in size post-tx. Or if EIRR had developed or progressed.

5
Q

What was the results of the study (per 50 canine teeth, %)

A

32 “successful”= 64%
14 “NEF”= 28%
4 “failed”= 8%

6
Q

What was the incidence of cats having at least 1 fractured tooth?

A

54.8%

7
Q

What does MTA Fillapex contain?

A
Salicylate resin
diluent resin
natural resin
bismuth oxide
nanoparticulated silica
titanium dioxide
MTA
8
Q

Was evidence of extrusion of MTA Fillapex associated with risk of RCT failure?

A

NO. Extrusion of Fillapex was not signif assoc w failure.

Periapical extrusion occurred in 7 (14%) of teeth

9
Q

Was evidence of external inflammatory root resorption (EIRR) signif associated with risk of failure of RCT?

A

No, not significantly assoc.

Decks in JVD 2019-2021 Class (44):